Rapporto sull’analisi delle dimensioni del mercato dei campioni di tessuti congelati e dell’analisi delle quote | Previsioni 2031

  • Report Code : TIPRE00016644
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 167
Buy Now

Si prevede che il mercato dei campioni di tessuti congelati raggiungerà i 105.045,91 mila dollari USA entro il 2028 rispetto ai 44.399,07 mila dollari USA del 2021. Si stima che il mercato crescerà a un CAGR del 13,1% nel corso del 2021-2028.

< p>I campioni di tessuto congelati sono preferiti in analisi quali sequenziamento di nuova generazione, western blotting per modifiche proteiche post-traduzionali, spettrometria di massa e reazione a catena della polimerasi quantitativa in tempo reale. I campioni di tessuto congelati rappresentano il gold standard per il sequenziamento del DNA e dell'RNA, soprattutto quando i filamenti devono essere più lunghi di 50 paia. I campioni di tessuto congelati sono utili anche in immunoistochimica poiché le proteine sono ancora conservate nel loro stato nativo.  

Approfondimenti strategici   

La crescita del mercato globale dei campioni di tessuti congelati è attribuita alla crescente applicazione di campioni di tessuti congelati in vari settori della ricerca e della ricerca. aree terapeutiche e il crescente utilizzo di campioni di tessuto congelati a causa della crescente prevalenza del cancro. Tuttavia, il rischio associato alla conservazione e al mantenimento dei campioni di tessuti congelati sta ostacolando in una certa misura la crescita del mercato globale dei campioni di tessuti congelati.

Regioni redditizie nel mercato dei campioni di tessuti congelati

Crescente utilizzo di campioni di tessuto congelati a causa della crescente prevalenza del cancro

Secondo i dati pubblicati da Cancer Research UK nel 2020, circa 0,16 milioni di persone nel Regno Unito muoiono ogni anno a causa del cancro. Inoltre, secondo il rapporto Globocan, nel 2020, il cancro al seno femminile ha superato il cancro del polmone come tumore più diagnosticato, con circa 2,3 milioni di nuovi casi (11,7%), seguito da quello del polmone (11,4%), del colon-retto (10,0%), della prostata (7,3%) e cancro allo stomaco (5,6%). Il cancro al polmone è rimasto la principale causa di morte per cancro, con circa 1,8 milioni di decessi (18%), seguito dal cancro del colon-retto (9,4%), del fegato (8,3%), dello stomaco (7,7%) e del seno femminile (6,9%). L’incidenza complessiva è stata da 2 a 3 volte superiore nei paesi in transizione rispetto ai paesi in transizione. Tuttavia, i decessi per cancro al seno e alla cervice nelle donne sono stati considerevolmente più alti nei paesi in transizione rispetto ai paesi in transizione. Una prevalenza così elevata di cancro sta determinando la necessità di campioni di tessuto congelati per la ricerca e lo studio. I crescenti studi che utilizzano campioni di tessuto tumorale congelato stabiliscono diversi ambiti di diagnosi e trattamento per questa condizione cronica. Pertanto, la crescente incidenza del cancro in tutto il mondo sta alimentando la crescita del mercato dei campioni di tessuti congelati. Inoltre, in Canada, il cancro è la principale causa di morte tra la popolazione, ed è la seconda causa dopo le malattie cardiache negli Stati Uniti. Secondo l’American Cancer Society, nel 2022 vengono diagnosticati circa 1,9 milioni di nuovi casi di cancro e si stimano 609.360 decessi negli Stati Uniti nel 2022. I tumori della prostata sono i tumori più comunemente diagnosticati tra i maschi del Nord America; tuttavia, i tumori al seno rimangono predominanti nelle donne. Inoltre, il cancro ai polmoni rimane la causa di morte più comune tra la popolazione. Si stima che il numero di nuovi casi di incidenza del cancro sia di 439,2 ogni 100.000 uomini e donne all'anno. Pertanto, la crescente prevalenza del cancro tra la popolazione sta portando alla crescita del mercato dei campioni di tessuti congelati in tutto il mondo.

Approfondimenti basati sul prodotto

Il mercato globale dei campioni di tessuti congelati, basato su prodotto, viene segmentato in campioni di tessuti normali congelati, campioni di tessuti tumorali congelati e campioni di tessuti malati congelati. Il segmento dei campioni di tessuti tumorali congelati ha detenuto la quota maggiore del mercato nel 2021. Inoltre, si prevede che lo stesso segmento registrerà il CAGR più elevato nel mercato dei campioni di tessuti congelati durante il periodo di previsione dal 2021 al 2028. La crescita è principalmente attribuita a aumento dei casi di tumore a livello globale.  

Mercato dei campioni di tessuti congelati, per prodotto - 2021 e 2028

Approfondimenti basati sull'applicazione

In base all'applicazione, il mercato globale dei campioni di tessuti congelati è segmentato in diagnosi e trattamento di malattie, cancro e altre malattie ricerca e analisi morfologica. Nel 2021, il segmento della ricerca sul cancro e altre malattie ha rappresentato la quota maggiore del mercato globale dei campioni di tessuti congelati. Tuttavia, si prevede che il segmento della diagnosi e del trattamento delle malattie crescerà al tasso CAGR più rapido, pari al 13,8% dal 2021 al 2028.

Approfondimenti basati sugli utenti finali

Il mercato globale dei campioni di tessuti congelati, in base all'utente finale, è segmentato in istituti accademici e di ricerca, ospedali e cliniche, centri diagnostici e altri. Nel 2021, il segmento degli istituti accademici e di ricerca deteneva la quota maggiore del mercato globale dei campioni di tessuti congelati. Tuttavia, si prevede che il segmento degli ospedali e delle cliniche crescerà al CAGR più rapido, pari al 13,9% dal 2021 al 2028.

Il lancio e le approvazioni dei prodotti sono strategie comunemente adottate dalle aziende per espandere la propria presenza globale e i portafogli di prodotti. Inoltre, gli operatori del mercato dei campioni di tessuti congelati si concentrano sulla strategia di partnership per ampliare la propria clientela, che, a sua volta, consente loro di mantenere il proprio marchio a livello globale. Si prevede che il mercato globale dei campioni di tessuti congelati fiorirà con lo sviluppo di nuovi prodotti innovativi da parte degli attori del mercato.

Profili aziendali

  • Audubon Bioscience Co
  • REPROCELL Inc.
  • Bay Biosciences LLC
  • US Biolab Corporation, Inc
  • AMS Biotechnology (Europe) Ltd.
  • Geneticist, Inc< /li>
  • ZenBio, Inc
  • OriGene Technologies, Inc.
  • BioChain Institute Inc
  • ProteoGenex, Inc.
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are Frozen Tissues Samples?

Frozen tissue samples are biospecimens preferred in analyses such as next-generation sequencing, western blotting for post-translational protein modifications, mass spectrometry, and quantitative real-time polymerase chain reaction. Frozen tissue samples are the gold standard for DNA and RNA sequencing, especially when the strands must be longer than 50 pairs. In immunohistochemistry, frozen tissue samples are also useful as the proteins are still preserved in their native state.

What are the driving factors for the Frozen Tissues Samples market across the globe?

The factors that are driving the growth of the market are rising application of frozen tissue samples in various research and therapeutic areas and risk associated with preservation and maintenance of frozen tissues samples. Moreover, the proliferation of biotechnology industry in developing regions provide growth opportunities to the frozen tissues samples market and developments in frozen tissue samples is expected to be a future trend that will drive the market’s growth in the coming years.

Which product will lead the Frozen Tissues Samples market?

The frozen tissue tumor samples segment was likely to hold the largest share of the market in 2021. Moreover, the same segment is anticipated to register the highest CAGR in the market during the forecast period of 2021 to 2028. The growth is mainly attributed due to increasing tumor cases globally.

Which end user will hold the largest share in the Frozen Tissues Samples market?

In 2021, the academic and research institutes segment was likely to hold the largest share of the market. However, the hospitals and clinics segment is expected to witness growth in its demand at the fastest CAGR of 13.8% during 2021 to 2028.

What is the regional market scenario of the Frozen Tissues Samples market?

The global Frozen Tissues Samples market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. Increasing incidence of cancer, growing need for diagnosing cancer, increasing competition between the market player, high R&D spending, and government grants for research institutes to develop new diagnosing methods are some of the prominent factors propelling the market growth in North America. Moreover, owing to the growing investments from international players in China and India. Aging population coupled with increasing demand for advanced medical technologies are expected to accelerate growth of the frozen tissues samples Market in Asia Pacific region.

Who are the major players in the Frozen Tissues Samples market?

The Frozen Tissues Samples market majorly consists of the players such as Audubon Bioscience Co; REPROCELL Inc.; Bay Biosciences LLC; US Biolab Corporation, Inc; AMS Biotechnology (Europe) Ltd.; Geneticist, Inc.; ZenBio, Inc.; OriGene Technologies, Inc.; BioChain Institute Inc.; and ProteoGenex, Inc., among others.

The List of Companies - Frozen Tissues Samples Market

  1. Audubon Bioscience Co
  2. REPROCELL Inc.
  3. Bay Biosciences LLC
  4. US Biolab Corporation, Inc.
  5. AMS Biotechnology (Europe) Ltd.
  6. Geneticist, Inc.
  7. ZenBio, Inc.
  8. OriGene Technologies, Inc.
  9. BioChain Institute Inc.
  10. ProteoGenex, Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports